AtaiBeckley Inc. - Common Stock (ATAI)

Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more radical, rapid-acting interventions. At the forefront of this neuro-psychiatric revolution stands GH Research PLC (Nasdaq: GHRS), a Dublin-based biopharmaceutical firm that has just crossed a critical threshold [...]

GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression.

Jefferies sees restrictions around non-recreational psychedelics eventually loosen up.

The company, which focuses on psychedelic-based medicine, had a busy few days on both the regulatory and financing fronts.

As of mid-October 2025, a compelling and diverse group of companies, spanning utilities, biotechnology, advanced materials, and defense, have seen their stocks reach impressive 52-week highs. This significant market event underscores a nuanced financial landscape where both defensive stability and high-growth innovation are being richly rewarded. The surge in valuations

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion sales by 2035.

Investors cheered good news from the lab delivered by the company.

Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 trials expected in 2026.

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),

Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a favorable safety profile.

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.